The Center has permitted Gujarat to conduct ‘Solidarity Trial’ for the deadly COVID-19, state government officials said. “The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19” the World Health Organization states.
A few days ago, a representative was chosen by Chief Minister Vijay Rupani before Union Home Minister Amit Shah a few days back to get permission.
“The Centre has given permission to conduct Solidarity Trial for the ‘Covid-19’ virus at BJ Medical College in Ahmedabad,” said a government official. The official also said that permissions to conduct similar trials at four other colleges were underway.
After getting permission for four other colleges of Gujarat, the registration of coronavirus positive patient and medical trials of four medicines under the ‘Solidarity Trial’ will begin at SVP College in Ahmedabad, GMERS Medical College at Gotri-Vadodara, Government Medical College and New Civil Hospital at Surat, and PDU Medical College at Rajkot.
“These four medicines are Remdesivir, Lopinavir, Interferon (beta 1 a) and hydroxychloroquine or Chloroquine. As a result of these experiments, an effective proper medicine for the Covid-19 will be found quickly. Not only this, but it will also enhance the probability of faster recovery of the infected patients,” the official added.
The World Health Organization (WHO), in association with other organizations in more than 100 countries across the world, is conducting the international clinical trial, ‘Solidarity Trial’, for the novel virus.
In India, the WHO is going to conduct ‘Solidarity Trial’ in association with the Indian Council of Medical Research (ICMR).